Umbilical Cord Blood Banking Market Trends 2011

This is the latest and most up-to-date Market Report from Select Biosciences addressing cord blood banking marketplace. In this report, we focus upon cord blood banking and provide quantitative market analysis of the space as it relates to the growth of the field, utilization trends of cord blood for different diseases in different countries of the world.

This report analyzes the umbilical cord blood marketplace from a technical as well as market perspective describing the types of transplantation utilizing cord blood, disease classes treated, size of public cord blood banking, associated growth, as well as market drivers and associated qualitative trends.

This data-driven characterization of the cord blood banking market landscape is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans.

Extensive Worldwide Market Analyses

Presented in this Report:

• Cord Blood Banking Quantitative Market Metrics
• Cord Blood in Cellular Therapy
• Factors Limiting Use of Allogeneic Transplantation
• Umbilical Cord Blood in Hematopoietic Stem Cell Transplantation
• Introduction to Diseases Treated with Cord Blood
• Engrafting Efficiency with Cord Blood
• Comparison of Cord Blood vs. Bone Marrow Transplants
• Transplantation Trends with Bone Marrow, Peripheral Blood, and Cord Blood: Market Penetrance
• Various Types of Stem Cells: Bone Marrow, Peripheral Blood Mononuclear Cells,and Cord Blood Used for Transplantation in Different Countries Around the World

Table of Contents

Chapter I. Executive Summary

Chronology of Cord Blood Transplantation

Cord Blood Banking Quantitative Market Metrics

Cord Blood in Cellular Therapy

Factors Limiting Use of Allogeneic Transplantation

Umbilical Cord Blood in Hematopoietic Stem Cell Transplantation

Chapter II. Market Analysis

An Introduction to Diseases Treated

Engrafting Efficiency with Cord Blood

US NMDP Transplant Trends

Transplantation Trends with Bone Marrow, Peripheral Blood, and Cord Blood: Market Penetrance

Comparison of Cord Blood vs. Bone Marrow Transplants

Number of Stem Cell Donors in Public Registries Worldwide and Growth Thereof

Number of Stored Cord Blood Units in Public Registries Worldwide and Growth Thereof

Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Sources Segregated by Recipient Age

Autologous Hematopoietic Stem Cell Sources Segregated by Recipient Age

Indications for Hematopoietic Stem Cell Transplantation—Quantitative Breakout

Various Types of Stem Cells: Bone Marrow, Peripheral Blood Mononuclear Cells, and Cord Blood Used for Transplantation in Different Countries Around the World

Appendix I. Research Methodology

More Reports in Pharmaceutical

EGIS Pharmaceuticals Plc: Pharmaceuticals and Healthcare Company Profile & SWOT Report


Blue Cross Blue Shield of Michigan: Pharmaceuticals and Healthcare Company Profile & SWOT Report


Purdue Pharma L.P.: Pharmaceuticals and Healthcare Company Profile & SWOT Report


Mitsubishi Tanabe Pharma Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Nissan Chemical Industries, Ltd.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Eisai Co., Ltd.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Asahi Kasei Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Perrigo Company: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Align Technology, Inc.: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


Daiichi Sankyo Company, Ltd: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

By This Publisher

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2012


MicroRNA Market Trends 2011


Circulating Tumor Cells (CTCs)Market Trends 2011


Umbilical Cord Blood Banking Market Trends 2011


Single Cell Omics 2011


Adult Stem Cells Market Trends 2011


Epigenetics Market Trends 2011


Cancer Vaccines & Circulating Tumor Cells (CTCs) 2011 Report


Multiplexed Diagnostics 2010 Market Report


Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine